HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoph Licht Selected Research

eculizumab

8/2020Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry.
10/2019Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.
4/2019Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study.
3/2018Long-term Eculizumab Therapy in a Child With Refractory Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
1/2018Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.
4/2016The alternative pathway of complement and the thrombotic microangiopathies.
3/2016Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
1/2016CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
5/2015Eculizumab hepatotoxicity in pediatric aHUS.
5/2015Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoph Licht Research Topics

Disease

22Atypical Hemolytic Uremic Syndrome
01/2022 - 02/2005
13Thrombotic Microangiopathies
08/2020 - 02/2005
10Hemolytic-Uremic Syndrome
12/2021 - 09/2004
9Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2022 - 09/2007
9Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 02/2009
9Proteinuria
01/2020 - 09/2007
8Infections
12/2021 - 09/2004
8Thrombotic Thrombocytopenic Purpura
01/2021 - 09/2004
8Hypertension (High Blood Pressure)
12/2020 - 02/2009
5Acute Kidney Injury (Acute Renal Failure)
12/2021 - 09/2004
4Meningococcal Infections
10/2019 - 05/2015
4Headache (Headaches)
01/2019 - 02/2014
4Dizziness (Lightheadedness)
01/2019 - 02/2014
4Respiratory Tract Infections (Respiratory Tract Infection)
09/2014 - 03/2009
3Kidney Diseases (Kidney Disease)
01/2022 - 09/2005
3Nephrotic Syndrome (Syndrome, Nephrotic)
03/2019 - 08/2010
3Hemolytic Anemia
01/2018 - 09/2004
3Glomerulonephritis
01/2017 - 02/2009
3Rare Diseases (Rare Disease)
11/2016 - 01/2007
3Hereditary Nephritis (Alport Syndrome)
07/2013 - 03/2009
3Hematuria
04/2012 - 03/2009
2Inflammation (Inflammations)
09/2021 - 06/2014
2Chronic Renal Insufficiency
09/2021 - 05/2015
2von Willebrand Diseases (von Willebrand's Disease)
01/2020 - 01/2016
2Vasculitis (Vasculitides)
01/2018 - 06/2014
2Thrombocytopenia (Thrombopenia)
01/2018 - 09/2004
2Leukemia
01/2017 - 06/2013
2Diarrhea
10/2014 - 04/2009
2Neoplasms (Cancer)
03/2013 - 06/2011
2Thrombosis (Thrombus)
06/2011 - 09/2009
2Complement Factor H Deficiency
01/2007 - 02/2005
1Stroke (Strokes)
01/2022
1MELAS Syndrome (Syndrome, MELAS)
01/2022
1Bone Diseases (Bone Disease)
09/2021
1COVID-19
01/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2021
1Vomiting
08/2020
1Chronic Disease (Chronic Diseases)
08/2020
1Nausea
08/2020
1Fatigue
08/2020
1Sepsis (Septicemia)
01/2020
1Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
01/2019
1Muscle Cramp (Cramp)
01/2019
1Pulmonary Arterial Hypertension
06/2018
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2018
1Bronchitis
01/2017
1Cysts
02/2016

Drug/Important Bio-Agent (IBA)

26Complement System Proteins (Complement)IBA
01/2021 - 02/2005
17eculizumabFDA Link
08/2020 - 09/2007
11Complement Factor H (Factor H)IBA
01/2018 - 02/2005
6Shiga Toxin (Shigella Toxin)IBA
12/2021 - 01/2016
6AutoantibodiesIBA
01/2018 - 02/2008
5thiamine triphosphorate (TTP)IBA
01/2018 - 09/2004
4Complement C3 (C3 Complement)IBA
01/2022 - 11/2013
4Proteins (Proteins, Gene)FDA Link
12/2020 - 02/2009
4CreatinineIBA
12/2020 - 03/2009
3Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 01/2006
3von Willebrand FactorIBA
01/2021 - 01/2016
3Antigen-Antibody Complex (Immune Complex)IBA
12/2020 - 01/2017
3Antihypertensive Agents (Antihypertensives)IBA
09/2014 - 02/2014
2Messenger RNA (mRNA)IBA
01/2020 - 04/2004
2Complement Inactivating AgentsIBA
04/2019 - 05/2015
2Pharmaceutical PreparationsIBA
11/2016 - 04/2014
2SteroidsIBA
12/2013 - 08/2010
2Dichlorodiphenyldichloroethane (DDD)IBA
02/2009 - 09/2007
1Biomarkers (Surrogate Marker)IBA
01/2022
1dimemorfan (AT 17)IBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1A 17 (A-17)IBA
01/2022
1Leu Transfer RNAIBA
01/2022
1Arginine (L-Arginine)FDA Link
01/2022
1VancomycinFDA LinkGeneric
04/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2020
1Puromycin AminonucleosideIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019
1C-Reactive ProteinIBA
01/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2019
1Parathyroid Hormone (Parathormone)IBA
01/2019
1Metalloproteases (Metalloproteinases)IBA
06/2018
1ThrombospondinsIBA
06/2018
1HomocysteineIBA
06/2018
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
06/2018
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2018
1Membrane Cofactor ProteinIBA
01/2018
1PlasticsIBA
01/2017
1Monoclonal AntibodiesIBA
04/2016
1Monomeric GTP-Binding ProteinsIBA
02/2016
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2016

Therapy/Procedure

21Therapeutics
08/2020 - 02/2005
6Kidney Transplantation
01/2022 - 09/2005
5Renal Dialysis (Hemodialysis)
01/2022 - 01/2006
2Hemodiafiltration
09/2021 - 04/2021
2Critical Care (Surgical Intensive Care)
01/2021 - 01/2004
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2021 - 04/2012
2Catheters
01/2020 - 01/2017
2Transplantation
06/2014 - 10/2010
2Drug Therapy (Chemotherapy)
06/2013 - 03/2013
1Immunomodulation
01/2019
1Blood Component Removal (Apheresis)
01/2017